• Published On : Dec-2017 |
  • Pages : 218 Pages |
  • Format :

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy
     2.3. Sterile Injectable Drugs Market Forecast Comparison

3. Market View Point
     3.1. Macro-Economic Factors
     3.2. Demand-Side Drivers
     3.3. Supply-Side Drivers
     3.4. Restraints
     3.5. Trends
     3.6. Opportunity Analysis
     3.7. Patent Expiration Scenario

4. North America Sterile Injectable Drugs Market Analysis 2012–2016 and Forecast 2017–2025
     4.1. Introduction
     4.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
            4.2.1. U.S.
            4.2.2. Canada
     4.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
            4.3.1. U.S.
            4.3.2. Canada
     4.4. Historical Market Size (US$ Mn) Analysis By Molecule Type, 2012–2016
            4.4.1. Small Molecules
            4.4.2. Large Molecules
     4.5. Market Size (US$ Mn) Forecast By Molecule Type, 2017–2025
            4.5.1. Small Molecules
            4.5.2. Large Molecules
     4.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2016
            4.6.1. Monoclonal Antibodies (mAbs)
            4.6.2. Cytokines
            4.6.3. Insulin
            4.6.4. Peptide hormones
            4.6.5. Vaccines
            4.6.6. Immunoglobulins
            4.6.7. Blood Factors
            4.6.8. Peptide antibiotics
            4.6.9. Others
     4.7. Market Size (US$ Mn) Forecast By Drug Type, 2017-2025
            4.7.1. Monoclonal Antibodies (mAbs)
            4.7.2. Cytokines
            4.7.3. Insulin
            4.7.4. Peptide hormones
            4.7.5. Vaccines
            4.7.6. Immunoglobulins
            4.7.7. Blood Factors
            4.7.8. Peptide antibiotics
            4.7.9. Others
     4.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
            4.8.1. Cancer
            4.8.2. Diabetes
            4.8.3. Cardiovascular Diseases
            4.8.4. Musculoskeletal
            4.8.5. CNS
            4.8.6. Infections
            4.8.7. Others
     4.9. Market Size (US$ Mn) Forecast By Application, 2017-2025
            4.9.1. Cancer
            4.9.2. Diabetes
            4.9.3. Cardiovascular Diseases
            4.9.4. Musculoskeletal
            4.9.5. CNS
            4.9.6. Infections
            4.9.7. Others
     4.10. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
            4.10.1. Intravenous
            4.10.2. Intramuscular (IM)
            4.10.3. Subcutaneous (SC)
            4.10.4. Others
     4.11. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2025
            4.11.1. Intravenous
            4.11.2. Intramuscular (IM)
            4.11.3. Subcutaneous (SC)
            4.11.4. Others
     4.12. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
            4.12.1. Hospital Pharmacies
            4.12.2. Retail Pharmacies
            4.12.3. Online Pharmacies
     4.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
            4.13.1. Hospital Pharmacies
            4.13.2. Retail Pharmacies
            4.13.3. Online Pharmacies
     4.14. Drivers and Restraints: Impact Analysis
     4.15. Market Attractiveness Analysis
            4.15.1. By Country
            4.15.2. By Molecule Type
            4.15.3. By Drug Type
            4.15.4. By Application
            4.15.5. By Route of Administration
            4.15.6. By Distribution Channel
     4.16. Key Representative Market Participants
     4.17. Key Participants Market Presence (Intensity Map)

5. Latin America Sterile Injectable Drugs Market Analysis 2012–2016 and Forecast 2017–2025
     5.1. Introduction
     5.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
            5.2.1. Brazil
            5.2.2. Mexico
            5.2.3. Rest of Latin America
     5.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
            5.3.1. Brazil
            5.3.2. Mexico
            5.3.3. Rest of Latin America
     5.4. Historical Market Size (US$ Mn) Analysis By Molecule Type, 2012–2016
            5.4.1. Small Molecules
            5.4.2. Large Molecules
     5.5. Market Size (US$ Mn) Forecast By Molecule Type, 2017–2025
            5.5.1. Small Molecules
            5.5.2. Large Molecules
     5.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2016
            5.6.1. Monoclonal Antibodies (mAbs)
            5.6.2. Cytokines
            5.6.3. Insulin
            5.6.4. Peptide hormones
            5.6.5. Vaccines
            5.6.6. Immunoglobulins
            5.6.7. Blood Factors
            5.6.8. Peptide antibiotics
            5.6.9. Others
     5.7. Market Size (US$ Mn) Forecast By Drug Type, 2017-2025
            5.7.1. Monoclonal Antibodies (mAbs)
            5.7.2. Cytokines
            5.7.3. Insulin
            5.7.4. Peptide hormones
            5.7.5. Vaccines
            5.7.6. Immunoglobulins
            5.7.7. Blood Factors
            5.7.8. Peptide antibiotics
            5.7.9. Others
     5.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
            5.8.1. Cancer
            5.8.2. Diabetes
            5.8.3. Cardiovascular Diseases
            5.8.4. Musculoskeletal
            5.8.5. CNS
            5.8.6. Infections
            5.8.7. Others
     5.9. Market Size (US$ Mn) Forecast By Application, 2017-2025
            5.9.1. Cancer
            5.9.2. Diabetes
            5.9.3. Cardiovascular Diseases
            5.9.4. Musculoskeletal
            5.9.5. CNS
            5.9.6. Infections
            5.9.7. Others
     5.10. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
            5.10.1. Intravenous
            5.10.2. Intramuscular (IM)
            5.10.3. Subcutaneous (SC)
            5.10.4. Others
     5.11. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2025
            5.11.1. Intravenous
            5.11.2. Intramuscular (IM)
            5.11.3. Subcutaneous (SC)
            5.11.4. Others
     5.12. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
            5.12.1. Hospital Pharmacies
            5.12.2. Retail Pharmacies
            5.12.3. Online Pharmacies
     5.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
            5.13.1. Hospital Pharmacies
            5.13.2. Retail Pharmacies
            5.13.3. Online Pharmacies
     5.14.Drivers and Restraints: Impact Analysis
     5.15. Market Attractiveness Analysis
            5.15.1. By Country
            5.15.2. By Molecule Type
            5.15.3. By Drug Type
            5.15.4. By Application
            5.15.5. By Route of Administration
            5.15.6. By Distribution Channel
     5.16. Key Representative Market Participants
     5.17. Key Participants Market Presence (Intensity Map)

6. Europe Sterile Injectable Drugs Market Analysis 2012–2016 and Forecast 2017–2025
     6.1. Introduction
     6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
            6.2.1. Germany
            6.2.2. France
            6.2.3. UK
            6.2.4. Italy
            6.2.5. Spain
            6.2.6. Russia
            6.2.7. Rest of Europe
     6.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
            6.3.1. Germany
            6.3.2. France
            6.3.3. UK
            6.3.4. Italy
            6.3.5. Spain
            6.3.6. Russia
            6.3.7. Rest of Europe
     6.4. Historical Market Size (US$ Mn) Analysis By Molecule Type, 2012–2016
            6.4.1. Small Molecules
            6.4.2. Large Molecules
     6.5. Market Size (US$ Mn) Forecast By Molecule Type, 2017–2025
            6.5.1. Small Molecules
            6.5.2. Large Molecules
     6.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2016
            6.6.1. Monoclonal Antibodies (mAbs)
            6.6.2. Cytokines
            6.6.3. Insulin
            6.6.4. Peptide hormones
            6.6.5. Vaccines
            6.6.6. Immunoglobulins
            6.6.7. Blood Factors
            6.6.8. Peptide antibiotics
            6.6.9. Others
     6.7. Market Size (US$ Mn) Forecast By Drug Type, 2017-2025
            6.7.1. Monoclonal Antibodies (mAbs)
            6.7.2. Cytokines
            6.7.3. Insulin
            6.7.4. Peptide hormones
            6.7.5. Vaccines
            6.7.6. Immunoglobulins
            6.7.7. Blood Factors
            6.7.8. Peptide antibiotics
            6.7.9. Others
     6.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
            6.8.1. Cancer
            6.8.2. Diabetes
            6.8.3. Cardiovascular Diseases
            6.8.4. Musculoskeletal
            6.8.5. CNS
            6.8.6. Infections
            6.8.7. Others
     6.9. Market Size (US$ Mn) Forecast By Application, 2017-2025
            6.9.1. Cancer
            6.9.2. Diabetes
            6.9.3. Cardiovascular Diseases
            6.9.4. Musculoskeletal
            6.9.5. CNS
            6.9.6. Infections
            6.9.7. Others
     6.10. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
            6.10.1. Intravenous
            6.10.2. Intramuscular (IM)
            6.10.3. Subcutaneous (SC)
            6.10.4. Others
     6.11. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2025
            6.11.1. Intravenous
            6.11.2. Intramuscular (IM)
            6.11.3. Subcutaneous (SC)
            6.11.4. Others
     6.12. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
            6.12.1. Hospital Pharmacies
            6.12.2. Retail Pharmacies
            6.12.3. Online Pharmacies
     6.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
            6.13.1. Hospital Pharmacies
            6.13.2. Retail Pharmacies
            6.13.3. Online Pharmacies
     6.14. Drivers and Restraints: Impact Analysis
     6.15. Market Attractiveness Analysis
            6.15.1. By Country
            6.15.2. By Molecule Type
            6.15.3. By Drug Type
            6.15.4. By Application
            6.15.5. By Route of Administration
            6.15.6. By Distribution Channel
     6.16. Key Representative Market Participants
     6.17. Key Participants Market Presence (Intensity Map)

7. Asia Pacific Sterile Injectable Drugs Market Analysis 2012–2016 and Forecast 2017–2025
     7.1. Introduction
     7.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
            7.2.1. Japan
            7.2.2. China
            7.2.3. India
            7.2.4. A&NZ
            7.2.5. ASEAN
            7.2.6. Rest of APAC
     7.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
            7.3.1. Japan
            7.3.2. China
            7.3.3. India
            7.3.4. A&NZ
            7.3.5. ASEAN
            7.3.6. Rest of APAC
     7.4. Historical Market Size (US$ Mn) Analysis By Molecule Type, 2012–2016
            7.4.1. Small Molecules
            7.4.2. Large Molecules
     7.5. Market Size (US$ Mn) Forecast By Molecule Type, 2017–2025
            7.5.1. Small Molecules
            7.5.2. Large Molecules
     7.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2016
            7.6.1. Monoclonal Antibodies (mAbs)
            7.6.2. Cytokines
            7.6.3. Insulin
            7.6.4. Peptide hormones
            7.6.5. Vaccines
            7.6.6. Immunoglobulins
            7.6.7. Blood Factors
            7.6.8. Peptide antibiotics
            7.6.9. Others
     7.7. Market Size (US$ Mn) Forecast By Drug Type, 2017-2025
            7.7.1. Monoclonal Antibodies (mAbs)
            7.7.2. Cytokines
            7.7.3. Insulin
            7.7.4. Peptide hormones
            7.7.5. Vaccines
            7.7.6. Immunoglobulins
            7.7.7. Blood Factors
            7.7.8. Peptide antibiotics
            7.7.9. Others
     7.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
            7.8.1. Cancer
            7.8.2. Diabetes
            7.8.3. Cardiovascular Diseases
            7.8.4. Musculoskeletal
            7.8.5. CNS
            7.8.6. Infections
            7.8.7. Others
     7.9. Market Size (US$ Mn) Forecast By Application, 2017-2025
            7.9.1. Cancer
            7.9.2. Diabetes
            7.9.3. Cardiovascular Diseases
            7.9.4. Musculoskeletal
            7.9.5. CNS
            7.9.6. Infections
            7.9.7. Others
     7.10. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
            7.10.1. Intravenous
            7.10.2. Intramuscular (IM)
            7.10.3. Subcutaneous (SC)
            7.10.4. Others
     7.11. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2025
            7.11.1. Intravenous
            7.11.2. Intramuscular (IM)
            7.11.3. Subcutaneous (SC)
            7.11.4. Others
     7.12. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
            7.12.1. Hospital Pharmacies
            7.12.2. Retail Pharmacies
            7.12.3. Online Pharmacies
     7.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
            7.13.1. Hospital Pharmacies
            7.13.2. Retail Pharmacies
            7.13.3. Online Pharmacies
     7.14. Drivers and Restraints: Impact Analysis
     7.15. Market Attractiveness Analysis
            7.15.1. By Country
            7.15.2. By Molecule Type
            7.15.3. By Drug Type
            7.15.4. By Application
            7.15.5. By Route of Administration
            7.15.6. By Distribution Channel
     7.16. Key Representative Market Participants
     7.17. Key Participants Market Presence (Intensity Map)

8. MEA Sterile Injectable Drugs Market Analysis 2012–2016 and Forecast 2017–2025
     8.1. Introduction
     8.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
            8.2.1. GCC Countries
            8.2.2. South Africa
            8.2.3. North Africa
            8.2.4. Rest of MEA
     8.3. Market Size (US$ Mn) Forecast By Country, , 2017–2025
            8.3.1. GCC Countries
            8.3.2. South Africa
            8.3.3. North Africa
            8.3.4. Rest of MEA
     8.4. Historical Market Size (US$ Mn) Analysis By Molecule Type, 2012–2016
            8.4.1. Small Molecules
            8.4.2. Large Molecules
     8.5. Market Size (US$ Mn) Forecast By Molecule Type, 2017–2025
            8.5.1. Small Molecules
            8.5.2. Large Molecules
     8.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2016
            8.6.1. Monoclonal Antibodies (mAbs)
            8.6.2. Cytokines
            8.6.3. Insulin
            8.6.4. Peptide hormones
            8.6.5. Vaccines
            8.6.6. Immunoglobulins
            8.6.7. Blood Factors
            8.6.8. Peptide antibiotics
            8.6.9. Others
     8.7. Market Size (US$ Mn) Forecast By Drug Type, 2017-2025
            8.7.1. Monoclonal Antibodies (mAbs)
            8.7.2. Cytokines
            8.7.3. Insulin
            8.7.4. Peptide hormones
            8.7.5. Vaccines
            8.7.6. Immunoglobulins
            8.7.7. Blood Factors
            8.7.8. Peptide antibiotics
            8.7.9. Others
     8.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
            8.8.1. Cancer
            8.8.2. Diabetes
            8.8.3. Cardiovascular Diseases
            8.8.4. Musculoskeletal
            8.8.5. CNS
            8.8.6. Infections
            8.8.7. Others
     8.9. Market Size (US$ Mn) Forecast By Application, 2017-2025
            8.9.1. Cancer
            8.9.2. Diabetes
            8.9.3. Cardiovascular Diseases
            8.9.4. Musculoskeletal
            8.9.5. CNS
            8.9.6. Infections
            8.9.7. Others
     8.10. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
            8.10.1. Intravenous
            8.10.2. Intramuscular (IM)
            8.10.3. Subcutaneous (SC)
            8.10.4. Others
     8.11. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2025
            8.11.1. Intravenous
            8.11.2. Intramuscular (IM)
            8.11.3. Subcutaneous (SC)
            8.11.4. Others
     8.12. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
            8.12.1. Hospital Pharmacies
            8.12.2. Retail Pharmacies
            8.12.3. Online Pharmacies
     8.13. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
            8.13.1. Hospital Pharmacies
            8.13.2. Retail Pharmacies
            8.13.3. Online Pharmacies
     8.14. Drivers and Restraints: Impact Analysis
     8.15. Market Attractiveness Analysis
            8.15.1. By Country
            8.15.2. By Molecule Type
            8.15.3. By Drug Type
            8.15.4. By Application
            8.15.5. By Route of Administration
            8.15.6. By Distribution Channel
     8.16. Key Representative Market Participants
     8.17. Key Participants Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape
     11.1. Competition Dashboard
     11.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
            11.2.1. Baxter International Inc.
            11.2.2. Sanofi
            11.2.3. GlaxoSmithKline plc.
            11.2.4. AstraZeneca Plc.
            11.2.5. Merck & Co., Inc.
            11.2.6. Novartis AG
            11.2.7. Pfizer Inc.
            11.2.8. GILEAD SCIENCES, INC.
            11.2.9. Johnson & Johnson Services, Inc.
            11.2.10. hameln group gmbh

12. Global Sterile Injectable Drugs Market Analysis 2012–2016 and Forecast 2017–2025, By Region
     12.1. Introduction
     12.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2016
            12.2.1. North America
            12.2.2. Latin America
            12.2.3. Europe
            12.2.4. Asia Pacific
            12.2.5. MEA
     12.3. Market Size (US$ Mn) Forecast By Region, 2017-2025
            12.3.1. North America
            12.3.2. Latin America
            12.3.3. Europe
            12.3.4. Asia Pacific
            12.3.5. MEA
     12.4. Market Attractiveness Analysis By Region

13. Global Sterile Injectable Drugs Market Analysis 2012–2016 and Forecast 2017–2025, By Molecule Type
     13.1. Historical Market Size (US$ Mn) Analysis By Molecule Type, 2012–2016
            13.1.1. Small Molecules
            13.1.2. Large Molecules
     13.2. Market Size (US$ Mn) Forecast By Molecule Type, 2017–2025
            13.2.1. Small Molecules
            13.2.2. Large Molecules
     13.3. Market Attractiveness Analysis By Molecule Type

14. Global Sterile Injectable Drugs Market Analysis 2012–2016 and Forecast 2017–2025, By Drug Type
     14.1. Introduction
     14.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2016
            14.2.1. Monoclonal Antibodies (mAbs)
            14.2.2. Cytokines
            14.2.3. Insulin
            14.2.4. Peptide hormones
            14.2.5. Vaccines
            14.2.6. Immunoglobulins
            14.2.7. Blood Factors
            14.2.8. Peptide antibiotics
            14.2.9. Others
     14.3. Market Size (US$ Mn) Forecast By Drug Type, 2017-2025
            14.3.1. Monoclonal Antibodies (mAbs)
            14.3.2. Cytokines
            14.3.3. Insulin
            14.3.4. Peptide hormones
            14.3.5. Vaccines
            14.3.6. Immunoglobulins
            14.3.7. Blood Factors
            14.3.8. Peptide antibiotics
            14.3.9. Others
     14.4. Market Attractiveness Analysis By Drug Type

15. Global Sterile Injectable Drugs Market Analysis 2012–2016 and Forecast 2017–2025, By Application
     15.1. Introduction
     15.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
            15.2.1. Cancer
            15.2.2. Diabetes
            15.2.3. Cardiovascular Diseases
            15.2.4. Musculoskeletal
            15.2.5. CNS
            15.2.6. Infections
            15.2.7. Others
     15.3. Market Size (US$ Mn) Forecast By Application, 2017-2025
            15.3.1. Cancer
            15.3.2. Diabetes
            15.3.3. Cardiovascular Diseases
            15.3.4. Musculoskeletal
            15.3.5. CNS
            15.3.6. Infections
            15.3.7. Others
     15.4. Market Attractiveness Analysis By Application

16. Global Sterile Injectable Drugs Market Analysis 2012–2016 and Forecast 2017–2025, By Route of Administration
     16.1. Introduction
     16.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
            16.2.1. Intravenous
            16.2.2. Intramuscular (IM)
            16.2.3. Subcutaneous (SC)
            16.2.4. Others
     16.3. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2025
            16.3.1. Intravenous
            16.3.2. Intramuscular (IM)
            16.3.3. Subcutaneous (SC)
            16.3.4. Others
     16.4. Market Attractiveness Analysis By Route of Administration

17. Global Sterile Injectable Drugs Market Analysis 2012–2016 and Forecast 2017–2025, By Distribution Channel
     17.1. Introduction
     17.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
            17.2.1. Hospital Pharmacies
            17.2.2. Retail Pharmacies
            17.2.3. Online Pharmacies
     17.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
            17.3.1. Hospital Pharmacies
            17.3.2. Retail Pharmacies
            17.3.3. Online Pharmacies
     17.4. Market Attractiveness Analysis By Distribution Channel

18. Global Market Analysis 2012–2016 and Forecast 2017–2025
     18.1. Market Size and Y-o-Y Growth
     18.2. Absolute $ Opportunity
     18.3. Value Chain

19. Research Methodology


List of Table

Table 01 : North America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
Table 02 : North America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Molecule Type
Table 03 : North America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
Table 04 : North America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Application
Table 05 : North America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
Table 06 : North America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
Table 07 : Latin America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
Table 08 : Latin America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Molecule Type
Table 09 : Latin America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
Table 10 : Latin America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Application
Table 11 : Latin America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
Table 12 : Latin America Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
Table 13 : Europe Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
Table 14 : Europe Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Molecule Type
Table 15 : Europe Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
Table 16 : Europe Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Application
Table 17 : Europe Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
Table 18 : Europe Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
Table 19 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
Table 20 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Molecule Type
Table 21 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
Table 22 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Application
Table 23 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
Table 24 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
Table 25 : MEA Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
Table 26 : MEA Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Molecule Type
Table 27 : MEA Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
Table 28 : MEA Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Application
Table 29 : MEA Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
Table 30 : MEA Sterile Injectable Drugs Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
Table 31 : Global Sterile Injectable Drugs Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Region 
Table 32 : Global Sterile Injectable Drugs Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Molecule Type
Table 33 : Global Sterile Injectable Drugs Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Drug Type
Table 34 : Global Sterile Injectable Drugs Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Application
Table 35 : Global Sterile Injectable Drugs Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Route of Administration
Table 36 : Global Sterile Injectable Drugs Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Distribution Channel


List of Figure

Figure 01 : Global Sterile Injectable Drugs Market Value Share, By Molecule Type  (2017)
Figure 02 : Global Sterile Injectable Drugs Market Value Share, By Drug Type (2017)
Figure 03 : Global Sterile Injectable Drugs Market Value Share, By Application (2017)
Figure 04 : Global Sterile Injectable Drugs Market Value Share, By Route of Administration (2017)
Figure 05 : Global Sterile Injectable Drugs Market Value Share, By Distribution Channel (2017)
Figure 06 : Global Sterile Injectable Drugs Market Value Share, By Region  (2017)
Figure 07 : North America Sterile Injectable Drugs Market Value Share, By Molecule Type (2017)
Figure 08 : North America Sterile Injectable Drugs Market Value Share, By Drug Type (2017)
Figure 09 : North America Sterile Injectable Drugs Market Value Share By Application (2017)
Figure 10 : North America Sterile Injectable Drugs Market Value Share, By Route of Administration (2017)
Figure 11 : North America Sterile Injectable Drugs Market Value Share, By Distribution Channel (2017)
Figure 12 : North America Sterile Injectable Drugs Market Value Share, By Country (2017)
Figure 13 : North America Sterile Injectable Drugs Market Forecast, 2017 and 2025
Figure 14 : North America Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 15 : North America Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 16 : U.S. Sterile Injectable Drugs Market Size Analysis, 2012–2016 
Figure 17 : U.S Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 18 : Canada Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 19 : Canada Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 20 : North America Sterile Injectable Drugs Market Attractiveness Analysis, By Molecule Type
Figure 21 : North America Sterile Injectable Drugs Market Attractiveness Analysis, By Drug Type
Figure 22 : North America Sterile Injectable Drugs Market Attractiveness Analysis, By Application
Figure 23 : North America Sterile Injectable Drugs Market Attractiveness Analysis, By Route of Administration
Figure 24 : North America Sterile Injectable Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 25 : North America Sterile Injectable Drugs Market Attractiveness Analysis, By Country
Figure 26 : Latin America Sterile Injectable Drugs Market Value Share, By Molecule Type (2017)
Figure 27 : Latin America Sterile Injectable Drugs Market Value Share, By Drug Type (2017)
Figure 28 : Latin America Sterile Injectable Drugs Market Value Share By Application (2017)
Figure 29 : Latin America Sterile Injectable Drugs Market Value Share, By Route of Administration (2017)
Figure 30 : Latin America Sterile Injectable Drugs Market Value Share, By Distribution Channel (2017)
Figure 31 : Latin America Sterile Injectable Drugs Market Value Share, By Country (2017)
Figure 32 : Latin America Sterile Injectable Drugs Market Forecast, 2017 and 2025
Figure 33 : Latin America Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 34 : Latin America Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 35 : Brazil Sterile Injectable Drugs Market Size Analysis, 2012–2016, 
Figure 36 : Brazil Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 37 : Mexico Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 38 : Mexico Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 39 : Rest of Latin America Sterile Injectable Drugs Market Size Analysis, 2012–2016, 
Figure 40 : Rest of Latin America Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 41 : Latin America Sterile Injectable Drugs Market Attractiveness Analysis, By Molecule Type
Figure 42 : Latin America Sterile Injectable Drugs Market Attractiveness Analysis, By Drug Type
Figure 43 : Latin America Sterile Injectable Drugs Market Attractiveness Analysis, By Application
Figure 44 : Latin America Sterile Injectable Drugs Market Attractiveness Analysis, By Route of Administration
Figure 45 : Latin America Sterile Injectable Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 46 : Latin America Sterile Injectable Drugs Market Attractiveness Analysis, By Country
Figure 47 : Europe Sterile Injectable Drugs Market Value Share, By Molecule Type (2017)
Figure 48 : Europe Sterile Injectable Drugs Market Value Share, By Drug Type (2017)
Figure 49 : Europe Sterile Injectable Drugs Market Value Share By Application (2017)
Figure 50 : Europe Sterile Injectable Drugs Market Value Share, By Route of Administration (2017)
Figure 51 : Europe Sterile Injectable Drugs Market Value Share, By Distribution Channel (2017)
Figure 52 : Europe Sterile Injectable Drugs Market Value Share, By Country (2017)
Figure 53 : Europe Sterile Injectable Drugs Market Forecast, 2017 and 2025
Figure 54 : Europe Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 55 : Europe Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 56 : Germany Sterile Injectable Drugs Market Size Analysis, 2012–2016, 
Figure 57 : Germany Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 58 : France Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 59 : France Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 60 : U.K. Sterile Injectable Drugs Market Size Analysis, 2012–2016, 
Figure 61 : U.K Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 62 : Italy Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 63 : Italy Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 64 : Spain Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 65 : Spain Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 66 : Russia Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 67 : Russia Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 68 : Rest of Europe Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 69 : Rest of Europe Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 70 : Europe Sterile Injectable Drugs Market Attractiveness Analysis, By Molecule Type
Figure 71 : Europe Sterile Injectable Drugs Market Attractiveness Analysis, By Drug Type
Figure 72 : Europe Sterile Injectable Drugs Market Attractiveness Analysis, By Application
Figure 73 : Europe Sterile Injectable Drugs Market Attractiveness Analysis, By Route of Administration
Figure 74 : Europe Sterile Injectable Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 75 : Europe Sterile Injectable Drugs Market Attractiveness Analysis, By Country
Figure 76 : Asia Pacific Sterile Injectable Drugs Market Value Share, By Molecule Type (2017)
Figure 77 : Asia Pacific Sterile Injectable Drugs Market Value Share, By Drug Type (2017)
Figure 78 : Asia Pacific Sterile Injectable Drugs Market Value Share By Application (2017)
Figure 79 : Asia Pacific Sterile Injectable Drugs Market Value Share, By Route of Administration (2017)
Figure 80 : Asia Pacific Sterile Injectable Drugs Market Value Share, By Distribution Channel (2017)
Figure 81 : Asia Pacific Sterile Injectable Drugs Market Value Share, By Country (2017)
Figure 82 : Asia Pacific Sterile Injectable Drugs Market Forecast, 2017 and 2025
Figure 83 : Asia Pacific Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 84 : Asia Pacific Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 85 : Japan Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 86 : Japan Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 87 : China Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 88 : China Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 89 : India Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 90 : India Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 91 : A&NZ Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 92 : A&NZ Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 93 : ASEAN Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 94 : ASEAN Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 95 : Rest of APAC Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 96 : Rest of APAC Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 97 : Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, By Molecule Type
Figure 98 : Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, By Drug Type
Figure 99 : Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, By Application
Figure 100 : Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, By Route of Administration
Figure 101 : Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 102 : Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, By Country
Figure 103 : MEA Sterile Injectable Drugs Market Value Share, By Molecule Type (2017)
Figure 104 : MEA Sterile Injectable Drugs Market Value Share, By Drug Type (2017)
Figure 105 : MEA Sterile Injectable Drugs Market Value Share By Application (2017)
Figure 106 : MEA Sterile Injectable Drugs Market Value Share, By Route of Administration (2017)
Figure 107 : MEA Sterile Injectable Drugs Market Value Share, By Distribution Channel (2017)
Figure 108 : MEA Sterile Injectable Drugs Market Value Share, By Country (2017)
Figure 109 : MEA Sterile Injectable Drugs Market Forecast, 2017 and 2025
Figure 110 : MEA Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 111 : MEA Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 112 : GCC Countries Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 113 : GCC Countries Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 114 : South Africa Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 115 : South Africa Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 116 : North Africa Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 117 : North Africa Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 118 : Rest of MEA Sterile Injectable Drugs Market Size Analysis, 2012–2016
Figure 119 : Rest of MEA Sterile Injectable Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 120 : MEA Sterile Injectable Drugs Market Attractiveness Analysis, By Molecule Type
Figure 121 : MEA Sterile Injectable Drugs Market Attractiveness Analysis, By Drug Type
Figure 122 : MEA Sterile Injectable Drugs Market Attractiveness Analysis, By Application
Figure 123 : MEA Sterile Injectable Drugs Market Attractiveness Analysis, By Route of Administration
Figure 124 : MEA Sterile Injectable Drugs Market Attractiveness Analysis, By Distribution Channel
Figure 125 : MEA Sterile Injectable Drugs Market Attractiveness Analysis, By Country
Figure 126 : Global Sterile Injectable Drugs Market Attractiveness Analysis By Region, 2017–2025
Figure 127 : Global Sterile Injectable Drugs Market Attractiveness Analysis By Molecule Type, 2017–2025
Figure 128 : Global Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2017–2025
Figure 129 : Global Sterile Injectable Drugs Market Attractiveness Analysis By Application, 2017–2025
Figure 130 : Global Sterile Injectable Drugs Market Attractiveness Analysis By Route of Administration, 2017–2025
Figure 131 : Global Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2017–2025
Figure 132 : Global Sterile Injectable Drugs Market Value Analysis and Forecast, 2016–2025 (US$ Mn)
Figure 133 : Global Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Mn), 2012–2016
Figure 134 : Global Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Mn), 2016–2025